Amedeo Smart

Free Medical Literature Service

 

Amedeo

COVID-19
  Free Subscription

08.08.2022

1 Am J Obstet Gynecol
2 Am J Respir Crit Care Med
4 Ann Intern Med
1 Antiviral Res
10 BMJ
12 Clin Infect Dis
7 Emerg Infect Dis
1 Eur J Radiol
1 Graefes Arch Clin Exp Ophthalmol
2 Infect Control Hosp Epidemiol
6 Int J Infect Dis
2 Intensive Care Med
6 J Infect
11 J Med Virol
7 J Virol
9 JAMA
3 Lancet
3 MMWR Morb Mortal Wkly Rep
1 N Engl J Med
6 Nature
1 Radiol Artif Intell
1 Radiology
1 Science
2 Travel Med Infect Dis
1 Zhonghua Jie He He Hu Xi Za Zhi


    Am J Obstet Gynecol

  1. VELASCO-REGULEZ B, Fernandez-Marquez JL, Luqui N, Cerquides J, et al
    Is the phase of the menstrual cycle relevant when getting the covid-19 vaccine?
    Am J Obstet Gynecol. 2022 Aug 2. pii: S0002-9378(22)00624.
    >> Share


    Am J Respir Crit Care Med

  2. SINNBERG T, Lichtensteiger C, Hasan Ali O, Pop OT, et al
    Pulmonary Surfactant Proteins are Inhibited by IgA Autoantibodies in Severe COVID-19.
    Am J Respir Crit Care Med. 2022 Aug 4. doi: 10.1164/rccm.202201-0011.
    >> Share

  3. MUNGMUNPUNTIPANTIP R, Wiwanitkit V
    CoronaVac or BNT162b2 Vaccine as a Third Dose.
    Am J Respir Crit Care Med. 2022;206:360-361.
    >> Share


    Ann Intern Med

  4. MONTORI VM
    Patients surviving COVID-19 had increased risk for incident diabetes vs. persons without COVID-19.
    Ann Intern Med. 2022 Aug 2. doi: 10.7326/J22-0052.
    >> Share

  5. BROPHY JM
    mRNA COVID-19 vaccines were linked to myocarditis at 28 d (0.15 to 10 excess events/100 000 vaccinated persons).
    Ann Intern Med. 2022 Aug 2. doi: 10.7326/J22-0057.
    >> Share

  6. AISENBERG GM
    In persons at risk for poor vaccination response or COVID-19 exposure, tixagevimab + cilgavimab reduced COVID-19.
    Ann Intern Med. 2022 Aug 2. doi: 10.7326/J22-0056.
    >> Share

  7. SALOMON JA, Bilinski A
    Evaluating the Performance of Centers for Disease Control and Prevention COVID-19 Community Levels as Leading Indicators of COVID-19 Mortality.
    Ann Intern Med. 2022 Aug 2. doi: 10.7326/M22-0803.
    >> Share


    Antiviral Res

  8. LI M, Chen J, Liu Y, Zhao J, et al
    Rational design of AAVrh10-vectored ACE2 functional domain to broadly block the cell entry of SARS-CoV-2 variants.
    Antiviral Res. 2022 Jul 30:105383. doi: 10.1016/j.antiviral.2022.105383.
    >> Share


    BMJ

  9. ELLIS SJ
    Covid-19 impact on patients: ease of access should be a clear aim of the NHS.
    BMJ. 2022;378:o1941.
    >> Share

  10. MAHASE E
    Covid-19: One in eight adults develops long covid symptoms, study suggests.
    BMJ. 2022;378:o1946.
    >> Share

  11. WARD IL, Bermingham C, Ayoubkhani D, Gethings OJ, et al
    Risk of covid-19 related deaths for SARS-CoV-2 omicron (B.1.1.529) compared with delta (B.1.617.2): retrospective cohort study.
    BMJ. 2022;378:e070695.
    >> Share

  12. LORENZO-REDONDO R, Ozer EA, Hultquist JF
    Covid-19: is omicron less lethal than delta?
    BMJ. 2022;378:o1806.
    >> Share

  13. DYER O
    Covid-19: Ontario hospitals close wards as nursing shortage bites.
    BMJ. 2022;378:o1917.
    >> Share

  14. HERETH B, Tubig P, Sorrels A, Muldoon A, et al
    Long covid and disability: a brave new world.
    BMJ. 2022;378:e069868.
    >> Share

  15. GRIFFIN S
    Covid-19: Staff absences in July surged amid ongoing pressure on hospitals.
    BMJ. 2022;378:o1909.
    >> Share

  16. NELSON B
    What poo tells us: wastewater surveillance comes of age amid covid, monkeypox, and polio.
    BMJ. 2022;378:o1869.
    >> Share

  17. REICHER S, Michie S, West R
    The UK government's "personal responsibility" policy for covid is hypocritical and unsustainable.
    BMJ. 2022;378:o1903.
    >> Share

  18. WISE J
    Long covid: Hair loss and sexual dysfunction are among wider symptoms, study finds.
    BMJ. 2022;378:o1887.
    >> Share


    Clin Infect Dis

  19. FOPPIANO PALACIOS C, Tucker EW, Travassos MA
    COVID-19 burden among unaccompanied minors in United States custody.
    Clin Infect Dis. 2022 Aug 5. pii: 6656047. doi: 10.1093.
    >> Share

  20. AWASTHI M, Golding H, Khurana S
    SARS-CoV-2 hyperimmune intravenous human immunoglobulins neutralizes Omicron subvariants BA.1, BA.2, BA.2.12.1, BA.3 and BA.4/BA.5 for treatment of COVID-19.
    Clin Infect Dis. 2022 Aug 4. pii: 6655744. doi: 10.1093.
    >> Share

  21. KLEYNHANS J, Walaza S, Martinson NA, Neti M, et al
    Household transmission of SARS-CoV-2 from adult index cases living with and without HIV in South Africa, 2020-2021: a case-ascertained, prospective observational household transmission study.
    Clin Infect Dis. 2022 Aug 4. pii: 6655792. doi: 10.1093.
    >> Share

  22. ZAMBRANO LD, Newhams MM, Olson SM, Halasa NB, et al
    BNT162b2 mRNA Vaccination Against COVID-19 is Associated with Decreased Likelihood of Multisystem Inflammatory Syndrome in U.S. Children Ages 5-18 Years.
    Clin Infect Dis. 2022 Aug 4. pii: 6655523. doi: 10.1093.
    >> Share

  23. PRAY IW, Grajewski B, Morris C, Modji K, et al
    Measuring work-related risk of COVID-19: comparison of COVID-19 incidence by occupation and industry - Wisconsin, September 2020-May 2021.
    Clin Infect Dis. 2022 Aug 4. pii: 6655522. doi: 10.1093.
    >> Share

  24. ARASHIRO T, Arima Y, Muraoka H, Sato A, et al
    COVID-19 vaccine effectiveness against symptomatic SARS-CoV-2 infection during Delta-dominant and Omicron-dominant periods in Japan: a multi-center prospective case-control study (FASCINATE study).
    Clin Infect Dis. 2022 Aug 3. pii: 6653543. doi: 10.1093.
    >> Share

  25. VIHTA KD, Pouwels KB, Peto TE, Pritchard E, et al
    Omicron-associated changes in SARS-CoV-2 symptoms in the United Kingdom.
    Clin Infect Dis. 2022 Aug 3. pii: 6653436. doi: 10.1093.
    >> Share

  26. KRISHNA BA, Metaxaki M, Wills MR, Sithole N, et al
    Reduced incidence of Long COVID referrals to the Cambridge University Teaching Hospital Long COVID clinic.
    Clin Infect Dis. 2022 Aug 1. pii: 6652885. doi: 10.1093.
    >> Share

  27. ATCHISON CJ, Moshe M, Brown JC, Whitaker M, et al
    Validity of self-testing at home with rapid SARS-CoV-2 antibody detection by lateral flow immunoassay.
    Clin Infect Dis. 2022 Aug 1. pii: 6652878. doi: 10.1093.
    >> Share

  28. MONTEJANO R, de la Calle-Prieto F, Velasco M, Guijarro C, et al
    Tenofovir Disoproxil Fumarate/Emtricitabine and Baricitinib for Patients at High Risk of Severe COVID-19: The PANCOVID Randomized Clinical Trial.
    Clin Infect Dis. 2022 Jul 30. pii: 6652179. doi: 10.1093.
    >> Share

  29. SINE K, Appaneal H, Dosa D, LaPlante KL, et al
    Antimicrobial Prescribing in the Telehealth Setting: Framework for stewardship during a period of rapid acceleration within primary care.
    Clin Infect Dis. 2022 Jul 30. pii: 6652160. doi: 10.1093.
    >> Share

  30. KERTES J, David SSB, Engel-Zohar N, Rosen K, et al
    Association between AZD7442 (tixagevimab-cilgavimab) administration and SARS-CoV-2 infection, hospitalization and mortality.
    Clin Infect Dis. 2022 Jul 29. pii: 6651663. doi: 10.1093.
    >> Share


    Emerg Infect Dis

  31. MUNNINK BBO, Nijhuis RHT, Worp N, Boter M, et al
    Highly Divergent SARS-CoV-2 Alpha Variant in Chronically Infected Immunocompromised Person.
    Emerg Infect Dis. 2022;28.
    >> Share

  32. SEID AG, Yirko T, Sayeed S, Plipat N, et al
    Infection with SARS-CoV-2 Omicron Variant 24 Days after Non-Omicron Infection, Pennsylvania, USA.
    Emerg Infect Dis. 2022;28.
    >> Share

  33. MEFSIN YM, Chen D, Bond HS, Lin Y, et al
    Epidemiology of Infections with SARS-CoV-2 Omicron BA.2 Variant, Hong Kong, January-March 2022.
    Emerg Infect Dis. 2022;28.
    >> Share

  34. ALLAN-BLITZ LT, Aboabdo B, Turner I, Klausner JD, et al
    Effect of Frequent SARS-CoV-2 Testing on Weekly Case Rates in Long-Term Care Facilities, Florida, USA.
    Emerg Infect Dis. 2022;28.
    >> Share

  35. HE D, Ali ST, Fan G, Gao D, et al
    Evaluation of Effectiveness of Global COVID-19 Vaccination Campaign.
    Emerg Infect Dis. 2022;28.
    >> Share

  36. WERNIKE K, Bottcher J, Amelung S, Albrecht K, et al
    Antibodies against SARS-CoV-2 Suggestive of Single Events of Spillover to Cattle, Germany.
    Emerg Infect Dis. 2022;28.
    >> Share

  37. NORZ D, Tang HT, Emmerich P, Giersch K, et al
    Rapid Adaptation of Established High-Throughput Molecular Testing Infrastructure for Monkeypox Virus Detection.
    Emerg Infect Dis. 2022;28.
    >> Share


    Eur J Radiol

  38. SARDANELLI F, Colarieti A
    Imaging of axillary lymph nodes in the COVID-19 era: A lesson to be learned.
    Eur J Radiol. 2022;154:110446.
    >> Share


    Graefes Arch Clin Exp Ophthalmol

  39. BAYYOUD T, Vavouras Syrigos G, Ruetalo Buschinger N, Wude J, et al
    Absence of detectable SARS-CoV-2 replication in ex vivo cultured cornea and cornea-derived epithelial cells.
    Graefes Arch Clin Exp Ophthalmol. 2022 Aug 3. pii: 10.1007/s00417-022-05776.
    >> Share


    Infect Control Hosp Epidemiol

  40. LI Y, Cai X, Mao Y, Cheng Z, et al
    Trends in racial and ethnic disparities in coronavirus disease 2019 (COVID-19) outcomes among nursing home residents.
    Infect Control Hosp Epidemiol. 2022;43:997-1003.
    >> Share

  41. LING ML, Cook AR, Marimuthu K, Pada S, et al
    A practical approach to defining aerosol-generating procedures.
    Infect Control Hosp Epidemiol. 2022;43:1083-1084.
    >> Share


    Int J Infect Dis

  42. LIANG Y, Mao X, Kuang M, Zhi J, et al
    IL-6 affects the severity of olfactory disorder: A cross-sectional survey of 148 patients who recovered from Omicron infection using the Sniffin' Sticks test in Tianjin, China.
    Int J Infect Dis. 2022 Aug 2. pii: S1201-9712(22)00468.
    >> Share

  43. ALMADHI M, Alsayyad AS, Conroy R, Atkin S, et al
    EPIDEMIOLOGICAL ASSESSMENT OF SARS-COV-2 REINFECTION.
    Int J Infect Dis. 2022 Aug 2. pii: S1201-9712(22)00470.
    >> Share

  44. DE OLIVEIRA JF, de Avila RE, de Oliveira NR, da Cunha Severino Sampaio N, et al
    Persistent symptoms, quality of life and risk factors in long COVID: a cross-sectional study of hospitalized patients in Brazil.
    Int J Infect Dis. 2022 Jul 28. pii: S1201-9712(22)00458.
    >> Share

  45. SRECKOVIC M, Marjanovic RR, Jovicic BP, Jankovic S, et al
    MULTISYSTEM INFLAMMATORY SYNDROME IN YOUNG ADULT SUCCESSFULLY TREATED WITH PLASMAPHERESIS, IMMUNOGLOBULINS AND CORTICOSTEROIDS: A CASE REPORT.
    Int J Infect Dis. 2022 Jul 28. pii: S1201-9712(22)00454.
    >> Share

  46. LI T, Song R, Wang J, Zhang J, et al
    Safety and immunogenicity of inactivated SARS-CoV-2 vaccines in people with gastrointestinal cancer.
    Int J Infect Dis. 2022 Jul 26. pii: S1201-9712(22)00446.
    >> Share

  47. DAHAL S, Mamelund SE, Luo R, Sattenspiel L, et al
    Investigating COVID-19 transmission and mortality differences among Indigenous and non-Indigenous populations in Mexico.
    Int J Infect Dis. 2022 Jul 26. pii: S1201-9712(22)00447.
    >> Share


    Intensive Care Med

  48. KNOX DB, Brunhoeber A, Peltan ID, Brown SM, et al
    Comparison of radiographic pneumothorax and pneumomediastinum in COVID-19 vs. non-COVID-19 acute respiratory distress syndrome.
    Intensive Care Med. 2022 Aug 5. pii: 10.1007/s00134-022-06816.
    >> Share

  49. ROSE L, Cook A, Onwumere J, Terblanche E, et al
    Psychological distress and morbidity of family members experiencing virtual visiting in intensive care during COVID-19: an observational cohort study.
    Intensive Care Med. 2022 Aug 1. pii: 10.1007/s00134-022-06824.
    >> Share


    J Infect

  50. NOH JY, Cheong HJ, Kim WJ, Choi JY, et al
    Robust neutralizing antibody responses after single-dose BNT162b2 vaccination at long intervals from prior SARS-CoV-2 infection and ceiling effect with repeated vaccination: Running title: Optimal vaccination interval and ceiling effect.
    J Infect. 2022 Jul 31. pii: S0163-4453(22)00456.
    >> Share

  51. BOJKOVA D, Stack R, Rothenburger T, Kandler JD, et al
    Synergism of interferon-beta with antiviral drugs against SARS-CoV-2 variants.
    J Infect. 2022 Jul 30. pii: S0163-4453(22)00455.
    >> Share

  52. MURPHY SL, Halvorsen B, Barratt-Due A, Am DR, et al
    Remdesivir modifies interferon response in hospitalized COVID-19 patients.
    J Infect. 2022 Jul 29. pii: S0163-4453(22)00450.
    >> Share

  53. DZINAMARIRA T, Moyo E, Moyo P, Pierre G, et al
    Childhood immunization services accessibility and utilization during the COVID-19 pandemic in Africa.
    J Infect. 2022 Jul 29. pii: S0163-4453(22)00445.
    >> Share

  54. PASCARELLA S, Ciccozzi M, Benvenuto D, Borsetti A, et al
    Peculiar Variations of the Electrostatic Potential of Spike Protein N-terminal Domain Associated with the Emergence of Successive SARS-CoV-2 Omicron Lineages.
    J Infect. 2022 Jul 28. pii: S0163-4453(22)00426.
    >> Share

  55. LINA L, Fangfang Z, Sevalie S, Dawei Z, et al
    Characteristics of SARS-CoV-2 exhaled by COVID-19 patients.
    J Infect. 2022 Jul 28. pii: S0163-4453(22)00424.
    >> Share


    J Med Virol

  56. ZHANG H, Ding Q, Yuan J, Han F, et al
    Susceptibility to mice and potential evolutionary characteristics of porcine deltacoronavirus.
    J Med Virol. 2022 Aug 4. doi: 10.1002/jmv.28048.
    >> Share


  57. Corrigendum.
    J Med Virol. 2022 Aug 4. doi: 10.1002/jmv.28046.
    >> Share

  58. SUNTRONWONG N, Kanokudom S, Auphimai C, Assawakosri S, et al
    Effects of boosted mRNA and adenoviral-vectored vaccines on immune responses to omicron BA.1 and BA.2 following the heterologous CoronaVac/AZD1222 vaccination.
    J Med Virol. 2022 Aug 4. doi: 10.1002/jmv.28044.
    >> Share


  59. Corrigendum.
    J Med Virol. 2022 Aug 2. doi: 10.1002/jmv.28043.
    >> Share

  60. LIM CC, Leeu JJ, Mok IY, Tan HZ, et al
    Influenza Vaccine Awareness and Acceptance in Kidney Disease during the Corononavirus Disease 2019 pandemic.
    J Med Virol. 2022 Aug 2. doi: 10.1002/jmv.28039.
    >> Share

  61. KOJIMA Y, Nakakubo S, Kamada K, Yamashita Y, et al
    Combination therapy with remdesivir and immunomodulators improves respiratory status in COVID-19: A retrospective study.
    J Med Virol. 2022 Aug 2. doi: 10.1002/jmv.28037.
    >> Share

  62. LIANG W, Wang S, Wang H, Li X, et al
    When 3D genome technology meets viral infection, including SARS-CoV-2.
    J Med Virol. 2022 Aug 2. doi: 10.1002/jmv.28040.
    >> Share

  63. PENG P, Deng H, Li Z, Chen Y, et al
    Distinct immune responses in the early phase to natural SARS-CoV-2 infection or vaccination.
    J Med Virol. 2022 Jul 29. doi: 10.1002/jmv.28034.
    >> Share

  64. MURPHY H, Ly H
    What are the levels of risk of humans contracting SARS-CoV-2 from pets and vice versa?
    J Med Virol. 2022 Jul 29. doi: 10.1002/jmv.28035.
    >> Share

  65. ALEXIEV I, Giovanetti M, Cella E, Ivanov I, et al
    Initial Introduction and Spread of the SARS-CoV-2 AY.4.2.1 Delta Variant in Bulgaria, a Genomic Insight.
    J Med Virol. 2022 Jul 28. doi: 10.1002/jmv.28033.
    >> Share

  66. ZHANG GF, Meng W, Chen L, Ding L, et al
    Neutralizing Antibodies to SARS-CoV-2 Variants of Concern Including Delta and Omicron in Subjects Receiving mRNA-1273, BNT162b2 and Ad26.COV2.S Vaccines.
    J Med Virol. 2022 Jul 28. doi: 10.1002/jmv.28032.
    >> Share


    J Virol

  67. ANDERSON-DANIELS J, Gribble J, Denison M
    Proteolytic Processing of the Coronavirus Replicase Nonstructural Protein 14 Exonuclease Is Not Required for Virus Replication but Alters RNA Synthesis and Viral Fitness.
    J Virol. 2022 Aug 4:e0084122. doi: 10.1128/jvi.00841.
    >> Share

  68. ABDELNABI R, Foo CS, Kaptein SJF, Boudewijns R, et al
    A SCID Mouse Model To Evaluate the Efficacy of Antivirals against SARS-CoV-2 Infection.
    J Virol. 2022 Aug 4:e0075822. doi: 10.1128/jvi.00758.
    >> Share

  69. CAMPAGNOLA G, Govindarajan V, Pelletier A, Canard B, et al
    The SARS-CoV nsp12 Polymerase Active Site Is Tuned for Large-Genome Replication.
    J Virol. 2022 Aug 4:e0067122. doi: 10.1128/jvi.00671.
    >> Share

  70. ZHAN W, Tian X, Zhang X, Xing S, et al
    Structural Study of SARS-CoV-2 Antibodies Identifies a Broad-Spectrum Antibody That Neutralizes the Omicron Variant by Disassembling the Spike Trimer.
    J Virol. 2022 Aug 4:e0048022. doi: 10.1128/jvi.00480.
    >> Share

  71. LI Z, Fang P, Duan P, Chen J, et al
    Porcine Deltacoronavirus Infection Cleaves HDAC2 to Attenuate Its Antiviral Activity.
    J Virol. 2022 Aug 2:e0102722. doi: 10.1128/jvi.01027.
    >> Share

  72. YUAN M, Chen X, Zhu Y, Dong X, et al
    A Bispecific Antibody Targeting RBD and S2 Potently Neutralizes SARS-CoV-2 Omicron and Other Variants of Concern.
    J Virol. 2022 Aug 2:e0077522. doi: 10.1128/jvi.00775.
    >> Share

  73. GUO H, Li A, Lin HF, Liu MQ, et al
    The Glycan-Binding Trait of the Sarbecovirus Spike N-Terminal Domain Reveals an Evolutionary Footprint.
    J Virol. 2022 Jul 19:e0095822. doi: 10.1128/jvi.00958.
    >> Share


    JAMA

  74. REWERS M, Bonifacio E, Ewald D, Geno Rasmussen C, et al
    SARS-CoV-2 Infections and Presymptomatic Type 1 Diabetes Autoimmunity in Children and Adolescents From Colorado, USA, and Bavaria, Germany.
    JAMA. 2022 Aug 5. pii: 2795226. doi: 10.1001/jama.2022.14092.
    >> Share

  75. MADHUSOODANAN J
    Animal Reservoirs-Where the Next SARS-CoV-2 Variant Could Arise.
    JAMA. 2022 Aug 3. pii: 2795140. doi: 10.1001/jama.2022.9789.
    >> Share

  76. LEVINE RL
    Addressing the Long-term Effects of COVID-19.
    JAMA. 2022 Aug 3. pii: 2795139. doi: 10.1001/jama.2022.14089.
    >> Share

  77. SLOMSKI A
    Sickle Cell Trait Associated With Kidney Failure and COVID-19 Death.
    JAMA. 2022;328:415.
    >> Share

  78. SLOMSKI A
    Maternal Death Rate Increased During Early COVID-19 Pandemic.
    JAMA. 2022;328:415.
    >> Share

  79. GENZEN JR, Rychert J, George TI
    Integrity of SARS-CoV-2 Laboratory-Developed Tests.
    JAMA. 2022;328:478.
    >> Share

  80. ADASHI EY, Cohen G
    Integrity of SARS-CoV-2 Laboratory-Developed Tests-Reply.
    JAMA. 2022;328:478-479.
    >> Share

  81. BIRNIE E, Biemond JJ, Appelman B, de Bree GJ, et al
    Development of Resistance-Associated Mutations After Sotrovimab Administration in High-risk Individuals Infected With the SARS-CoV-2 Omicron Variant.
    JAMA. 2022 Aug 1. pii: 2794999. doi: 10.1001/jama.2022.13854.
    >> Share

  82. VASAN A, Foote M, Long T
    Ensuring Widespread and Equitable Access to Treatments for COVID-19.
    JAMA. 2022 Jul 29. pii: 2794967. doi: 10.1001/jama.2022.13554.
    >> Share


    Lancet


  83. Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis.
    Lancet. 2022;400:359-368.
    >> Share

  84. THORNTON J
    Violence against health workers rises during COVID-19.
    Lancet. 2022;400:348.
    >> Share

  85. MEHTA P, Titanji BK
    Baricitinib in COVID-19: a coming-of-age from artificial intelligence to reducing mortality.
    Lancet. 2022;400:338-339.
    >> Share


    MMWR Morb Mortal Wkly Rep

  86. KHUON D, Ogrin S, Engels J, Aldrich A, et al
    Notes from the Field: Increase in Pediatric Intracranial Infections During the COVID-19 Pandemic - Eight Pediatric Hospitals, United States, March 2020-March 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:1000-1001.
    >> Share

  87. TWENTYMAN E, Wallace M, Roper LE, Anderson TC, et al
    Interim Recommendation of the Advisory Committee on Immunization Practices for Use of the Novavax COVID-19 Vaccine in Persons Aged >/=18 years - United States, July 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:988-992.
    >> Share

  88. KOMPANIYETS L, Bull-Otterson L, Boehmer TK, Baca S, et al
    Post-COVID-19 Symptoms and Conditions Among Children and Adolescents - United States, March 1, 2020-January 31, 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:993-999.
    >> Share


    N Engl J Med

  89. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Updated Covid-19 Vaccines and a Look at Monkeypox.
    N Engl J Med. 2022;387:e16.
    >> Share


    Nature


  90. Mild-COVID drugs, Omicron protection and disco-ball satellite.
    Nature. 2022;608:13.
    >> Share


  91. Get childhood immunizations back on track after COVID.
    Nature. 2022;608:7-8.
    >> Share


  92. A first update on mapping the human genetic architecture of COVID-19.
    Nature. 2022;608:E1-E10.
    >> Share

  93. CHU H, Hou Y, Yang D, Wen L, et al
    Coronaviruses exploit a host cysteine-aspartic protease for replication.
    Nature. 2022 Aug 3. pii: 10.1038/s41586-022-05148.
    >> Share

  94. SIDIK SM
    Heart disease after COVID: what the data say.
    Nature. 2022;608:26-28.
    >> Share

  95. BAKER N, Maxmen A
    Coronapod: the open-science plan to unseat big Pharma and tackle vaccine inequity.
    Nature. 2022 Jul 29. pii: 10.1038/d41586-022-02094.
    >> Share


    Radiol Artif Intell

  96. SUN J, Peng L, Li T, Adila D, et al
    Performance of a Chest Radiograph AI Diagnostic Tool for COVID-19: A Prospective Observational Study.
    Radiol Artif Intell. 2022;4:e210217.
    >> Share


    Radiology

  97. SELLERGREN AB, Chen C, Nabulsi Z, Li Y, et al
    Simplified Transfer Learning for Chest Radiography Models Using Less Data.
    Radiology. 2022 Jul 19:212482. doi: 10.1148/radiol.212482.
    >> Share


    Science

  98. COHEN J
    Making broader coronavirus vaccines is a struggle.
    Science. 2022;377:566-567.
    >> Share


    Travel Med Infect Dis

  99. SHAFAATI M, Zandi M
    Monkeypox virus neurological manifestations in comparison to other orthopoxviruses.
    Travel Med Infect Dis. 2022 Aug 1:102414. doi: 10.1016/j.tmaid.2022.102414.
    >> Share

  100. LI C, Zhu X, Zhang Y, Zhang J, et al
    COVID-19 influences both physical and mental health: Lessons from bibliometric analysis.
    Travel Med Infect Dis. 2022 Jul 30:102405. doi: 10.1016/j.tmaid.2022.102405.
    >> Share


    Zhonghua Jie He He Hu Xi Za Zhi

  101. LONG QY, Zheng YL, Gao Z
    [Advances in SARS-CoV-2 diagnostic strategies during the later COVID-19 era].
    Zhonghua Jie He He Hu Xi Za Zhi. 2022;45:819-825.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016